TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Inter-reader reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Loss of coronal reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No major adverse cardiac events
Endpoint domain: Adverse events/effects
Primary endpoint: Standard deviation of heart inter-beat intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accurate discrimination of clinically significant prostate cancer (csPCa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: dyspnoea (mMRC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: microbiological success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reduction in serum CRP value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of hepatic encephalopathy (HE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of developing infection
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in SF-36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in ASAS HI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: local PPT improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infarction volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach targeted sedation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiologist's satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of allergic conjunctivitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in evidence-based bronchiolitis management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower flare rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher rates of attainment of sustained oral glucocorticoid taper to ≤7.5 mg/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer SLE-related hospitalizations/emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Prevalence of excessive screen time
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: fastest response time (FRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean response time (MRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: number of correct answers (NCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 30-s chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable flow in AVFs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Morphological changes in AVFs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-frontal oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-time screening odds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual screening odds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased frontal activity during memory encoding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increased neural synchronization in higher-order cognitive regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in performance on neuropsychological tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: retention test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration‐Aspiration Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residue rate of pyriform fossa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residue rate of epiglottis valley
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptoms of mental health problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine and plasma metabolites after apple intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gout episodes or initiation of antigout treatment
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of any new fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adherence to probiotic use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: self-assessed pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent decrease in mean STAI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SDT percent changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean-fold increases in antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean longest breath-hold times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titres (GMTs) of HBGA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety concerns related to vaccine formulations
Endpoint domain: Adverse events/effects
Primary endpoint: WCE prevalence in patients with OH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Non-dipping pattern prevalence in patients with OH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptance of HIVST kit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Usage of HIVST kit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reactive result from HIVST kit
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in condomless anal sex acts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reduction of viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: time to complete resolution of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Happiness level of students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: rate of immune-related adverse events (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: bone union progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracellular volume fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global strain analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional strain analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of conversational turns
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Kansas City Cardiomyopathy Questionnaire Overall Summary Score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean score for attitude and beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ODT (Oral Dysphagia Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OTT (Oral Transit Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Margaria‐Kalamen stair climb test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking velocity on treadmill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scar erythema improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain improvement (at least 30% reduction on basal pain score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical aggression toward partners (PA-P)
Endpoint domain: Adverse events/effects
Primary endpoint: Physical aggression toward non-partners (PA-NP)
Endpoint domain: Adverse events/effects
Primary endpoint: Physical injury of non-partners (PI-NP)
Endpoint domain: Adverse events/effects
Primary endpoint: Discussion of patient-important issues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of stroke discussion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bacterial count reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma concentration of ginkgolide B and C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mixed muscle FSRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: risk of PJI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: effectiveness of AP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Central Systolic Blood Pressure (cSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reflected Pressure Pulse Height (RPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: VO2 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived benefits of PPI-ePR system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: VO2 peak uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2-VT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OUES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain relief on the third day of analgesic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drug cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of postoperative scar complications
Endpoint domain: Adverse events/effects
Primary endpoint: shoulder joint amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: hip-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Owner-reported activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in understanding of anatomy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in grades
Endpoint domain: Life impact
Endpoint subdomain: Academic performance
Primary endpoint: DAS28‐ESR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of rheumatologist consultations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Predictive ability of survival
Endpoint domain: Mortality/survival
Primary endpoint: ≥ Stage 2 pelvic organ prolapse at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing complication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regeneration rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean annual costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incremental net monetary benefit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: hSBA titers ≥ lower limit of quantitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DHI total score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Diabetic Hemorrhage (DH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Intraretinal Microvascular Abnormalities (IRMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liking for activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum output (Omax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Barthel Index (MBI) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: General Self‐efficacy Scale (GSES) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Zung's Self‐rating Anxiety Scale (SAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Documentation of anticoagulation management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum lip pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: persistence of symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Final enrollment of caregivers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Probability of death at 6, 12, and 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Self-harm frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isometric neck strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Institutional delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Exclusive breastfeeding from birth to 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Fully immunized child
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Estimated mean change in Alzheimer Disease Assessment Scale‐Cognitive Subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma NA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Faces Pain Scale‐Revised score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intention to donate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: levels of IL‐6 and tumour necrosis factor‐α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL‐6/IL‐10 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Duration for the requirement of the first rescue analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Videos watched to completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Video ratings (satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in daily OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ON time without troublesome dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in daily levodopa-equivalent dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device system extraction
Endpoint domain: Adverse events/effects
Primary endpoint: Negative automatic thoughts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-year local recurrence free survival (LRFS)
Endpoint domain: Mortality/survival
Primary endpoint: 7-year disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: 7-year overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: Accuracy of perceptions of diabetes seriousness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants reporting a diabetes management goal
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: subjective stress urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: objective stress urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Duration of NTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged mechanical ventilation (MV)
Endpoint domain: Mortality/survival
Primary endpoint: KSFS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Risk of subsequent diagnosis of HGD or OAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of moderate-to-severe AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total incidence of AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 6 month continuous abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in anxiety scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall improvement in health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost per person reached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative risk of short sleeping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence for dialoguing with voices
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative live birth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Push effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived difficulty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postprandial glucose (PPG) levels at 1 and 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in ACC myo-inositol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in protein glycosylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death from all causes on day 30
Endpoint domain: Mortality/survival
Primary endpoint: readmittance or death within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Serum levels of 25(OH) D
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLP-1 levels after meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fasting proinsulin to insulin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Average appetite scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GMT ratios of HPV‐16 and HPV‐18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean FVC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: discontinuation due to infections
Endpoint domain: Adverse events/effects
Primary endpoint: tubule patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum creatinine levels at 28-day follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of correct answers for incidental findings knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental efficacy and children's oral health behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Long-term visual analog scale score for back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoperation rate at 2 years after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Success rates in terms of ZCQ score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: improvement in gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: additional life‐years
Endpoint domain: Mortality/survival
Primary endpoint: sports participation and activity goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sports-specific physical competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement for depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement for behavioral symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes